<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20191218045786N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-03-02</date_registration>
      <primary_sponsor>University of  Lahore , Main Campus</primary_sponsor>
      <public_title>Stabilization Exercises  for elderly patients with back pain</public_title>
      <acronym></acronym>
      <scientific_title>The effects of stabilization exercises in addition to routine physical therapy in elderly patients with back pain; A randomized controlled trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-01-29</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>72</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/44507</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Other, Purpose: Treatment, Other design features: Patients, once accepted into the study will be randomly assigned to a treatment group by Chit-box method, either experimental group (stabilization exercises and routine Physical therapy or control group (routine physical therapy and stretching exercises). There will be added co-intervention and home program for both groups. This will be parallel group randomized controlled trial with 1:1 allocation ratio into two groups. Each patient therefore will have an equal chance of being selected in either group.                                      For random allocation of at least 60 cases into two groups equally, prepare 60 chits writing “C” (for Control group) on 30 chits and “E” (for Experimental group) on 30 chits. After folding the chits and putting in a box and well mixing, draw a chit, note the letter written on it, and then draw the second chit without replacing the first, note it and proceed similarly until the last i.e. 60th chit is drawn. . The first case registered will go to the control group, second group to the experimental group and the sequence will be continued till the selection of the last participant.                                                                                                                        The treatment procedures will be repeated for 5 sessions of 45 minutes each per week for 4 weeks (20 sessions).The Post-test scores of Visual analogue scale (VAS), berg balance scale (BBS), trunk muscles endurance tests, trunk range of motion (ROM) and functional disability will be collected after one month of treatment administration.                                                                                                                                     The patients will have to read the letter of information and if they agree to participate then they will be asked to sign the letter of consent before they are allowed to participate in the study. All the patients can contact to the researcher in order to find out any further information regarding their participation in the study. The participants will be provided the facility as per required for the research. The health of the patients will be on priority and all the patients will be free to withdrawn anytime, Randomization description: A single bind  randomized controlled design will be used.Assessor will be blinded in the present study.Patients, once accepted into the study will be randomly assigned to a treatment group by Chit-box method, either experimental group (stabilization exercises and routine 
Physical therapy or control group (routine physical therapy and stretching exercises). There will be added co-intervention and home program for both groups.
This will be parallel group randomized controlled trial with 1:1 allocation ratio into two groups. Each patient therefore will have an equal chance of being selected in either group.  
The patients will be allocated into two groups i.e. Experimental group and control group by randomization through Chit-box method. Experimental group patients will be treated with stabilization exercises and routine physical therapy while those of control group will be treated with routine physical therapy and stretching exercises. 
Chit-Box Method: For random allocation  at least 60 cases into two groups equally, prepare 60 chits writing “C” (for Control group) on 30 chits and “E” (for Experimental group) on 30 chits. After folding the chits and putting in a box and well mixing, draw a chit, note the letter written on it, and then draw the second chit without replacing the first, note it and proceed similarly until the last i.e. 60th chit is drawn. According to the sequence the first case registered will go to the control group, second case to the experimental group and will continue the sequence till last participant selection, Blinding description: This will be a single blinded randomized controlled trial .The assessor will only be kept blinded in this research study. The relevant details of the research study will be given to the participants at the time of taking consent; however they will remain unaware of their own group allocation. The assessor will remain unaware about who will be selected as research sample participants including unaware about experimental and control groups. The physical therapist will not be allowed to take the pre-post score outcome measurements. The assessors  will not know the details of the treatment. The principal investigator alone will administer the treatment. Final session outcome measurements (post intervention) will be recorded by the above mentioned assessor.</study_design>
      <phase>4</phase>
      <hc_freetext>Chronic Back pain.</hc_freetext>
      <i_freetext>Intervention 1: Experimental Group: The participants of the experimental group will perform routine Physiotherapy exercise plus specific Stabilization exercises of the back. The duration of the exercises will be 45 minutes.There will be total 20 sessions( 4 weeks ), including 5 sessions/ week. Intervention 2: Control group: The participants of the Control  group will perform routine Physiotherapy exercise plus stretching exercises of the back. The duration of the exercises will be 45 minutes. There will be total 20 sessions( 4 weeks ), including 5 sessions/ week.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All collected deidentified IPD

When:
Data will be available to the other people after the completion of  the study and will remained available till 6 months

To whom:
Data will be  available for the  people working in academic institutions

Conditions:
Data will be shared for  the purpose  of RCT and other interventional research studies. Data can be accessed by communicating with principle invigilator" Muhammad Shahid" through email address: Shahidmirkhan@yahoo.com

Where to obtain:
Data is available by communicating with principle invigilator" Muhammad Shahid" through email address: Shahidmirkhan@yahoo.com

How to obtain:
Data/document  can be accessed by communicating with principle invigilator" Muhammad Shahid" through email address: Shahidmirkhan@yahoo.com

Comments:
N/A</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr. Muhammad Shahid</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>University of Lahore, Main Campus, Lahore 1-KM Defence Road.off bhopatian Chowk, Lahore</address>
        <city>Lahore</city>
        <country1>Pakistan</country1>
        <zip>54000</zip>
        <telephone>+92 42 99200600</telephone>
        <email>Shahidmirkhan@yahoo.com</email>
        <affiliation>University of Lahore</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Muhammad Shahid</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>University of Lahore, Main Campus 1-KM Defence Road.off bhopatian Chowk, Lahore</address>
        <city>Lahore</city>
        <country1>Pakistan</country1>
        <zip>54000</zip>
        <telephone>+92 42 99200600</telephone>
        <email>Shahidmirkhan@yahoo.com</email>
        <affiliation>University of Lahore, Main Campus</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Pakistan</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age group  60 years and above
Both male and female patients
Elderly with chronic backache(more than 3 months)
Independent gait ability with or without walking aid for a minimum of 15 m.
Adequate vision and hearing for completion of  the study protocol, as indicated by the ability to follow written and oral instructions during screening
Capacity to understand and follow instructions
Elderly with adequate stamina to perform stabilization</inclusion_criteria>
      <agemin>60 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>A history of stroke or other neurologic diseases or disorders
Subjects with specific pathology, such as systemic inflammatory diseases (e.g. systemic lupus erythematous(SLE), rheumatoid arthritis(RA), nephritis etc.), prolapsed disc(PD), fractures and deformities (spine or extremities), bone tumors and bone infections
Pain, limited motion, or weakness in the lower extremity that affects performance of daily activities (by self-report)
Vestibular dysfunctions e.g. Benign Paroxysmal Positional Vertigo (BPPV)
Acute cardiac surgeries e.g. Coronary artery bypass grafting (CABG`s )
Unstable angina e.g. Myocardial infarction (MI)
Persistent pulmonary pathology( e.g. exertional  dyspnoea (ED)</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M54.5</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Low back pain</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Experimental Group: The participants of the experimental group will perform routine Physiotherapy exercise plus specific Stabilization exercises of the back. The duration of the exercises will be 45 minutes.There will be total 20 sessions( 4 weeks ), including 5 sessions/ week.</i_keyword>
      <i_keyword>Control group: The participants of the Control  group will perform routine Physiotherapy exercise plus stretching exercises of the back. The duration of the exercises will be 45 minutes. There will be total 20 sessions( 4 weeks ), including 5 sessions/ week</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Back Pain. Timepoint: Before  intervention and  at 4 weeks  after intervention. Method of measurement: Scoring by VAS ( Visual Analigue Scale ).</prim_outcome>
      <prim_outcome>ROM (Range of Motion). Timepoint: Before  intervention and  at 4 weeks  after intervention. Method of measurement: Scoring , Degree measurement  by Goniometer.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Endurance  of Trunk Flexors and  Extensors. Timepoint: Before intervention and at 4 weeks after intervention. Method of measurement: Scoring by Endurance Tests.</sec_outcome>
      <sec_outcome>Balance. Timepoint: Before intervention and at 4 weeks after intervention. Method of measurement: Berg Balance  Scale.</sec_outcome>
      <sec_outcome>Functional Disability. Timepoint: Before intervention and at 4 weeks after intervention. Method of measurement: Oswestry Disability Index.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>University of  Lahore , Main Campus</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-09-20</approval_date>
        <contact_name>Instituitional Review Board ( IRB), University of  Lahore, Lahore, Pakistan</contact_name>
        <contact_address>1-KM Defence Road.off bhopatian Chowk, Lahore Lahore Punjab Pakistan</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
